Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinuko Tajima

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimenDai Maruyama, Takahiro Fukuda, Ruri Kato, et al.
Annals of Hematology|December 9, 2016
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatmentHideaki Kitahara, Dai Maruyama, Akiko Miyagi Maeshima, et al.
Cancer Medicine|June 9, 2021
Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapyTomotaka Suzuki, Dai Maruyama, Akiko Miyagi-Maeshima, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 24, 2016
Clinical Outcomes after Allogeneic Stem Cell Transplantation for Adult Lymphoblastic LymphomaShinichi Makita, Shigeo Fuji, Kuniko Takano, et al.
European Journal of Haematology|September 6, 2019
Association of CD204<sup>+</sup> macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCTAkihisa Kawajiri, Shigehisa Kitano, Akiko Miyagi Maeshima, et al.
Bone Marrow Transplantation|January 17, 2018
Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sourcesTakafumi Shichijo, Shigeo Fuji, Kinuko Tajima, et al.
European Journal of Haematology|October 24, 2020
The role of local radiotherapy following rituximab-containing chemotherapy in patients with transformed indolent B-cell lymphomaKenji Nozaki, Dai Maruyama, Akiko Miyagi Maeshima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2004
Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantationAkiko Hori, Masahiro Kami, Sung-Won Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2016
Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host DiseaseYayoi Matsumura-Kimoto, Yoshihiro Inamoto, Kinuko Tajima, et al.
American Journal of Hematology|May 30, 2012
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphomaKohei Tada, Sung-Won Kim, Yoshitaka Asakura, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimenDai Maruyama, Takahiro Fukuda, Ruri Kato, et al.
Annals of Hematology|December 9, 2016
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatmentHideaki Kitahara, Dai Maruyama, Akiko Miyagi Maeshima, et al.
Cancer Medicine|June 9, 2021
Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapyTomotaka Suzuki, Dai Maruyama, Akiko Miyagi-Maeshima, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 24, 2016
Clinical Outcomes after Allogeneic Stem Cell Transplantation for Adult Lymphoblastic LymphomaShinichi Makita, Shigeo Fuji, Kuniko Takano, et al.
European Journal of Haematology|September 6, 2019
Association of CD204<sup>+</sup> macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCTAkihisa Kawajiri, Shigehisa Kitano, Akiko Miyagi Maeshima, et al.
Bone Marrow Transplantation|January 17, 2018
Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sourcesTakafumi Shichijo, Shigeo Fuji, Kinuko Tajima, et al.
European Journal of Haematology|October 24, 2020
The role of local radiotherapy following rituximab-containing chemotherapy in patients with transformed indolent B-cell lymphomaKenji Nozaki, Dai Maruyama, Akiko Miyagi Maeshima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2004
Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantationAkiko Hori, Masahiro Kami, Sung-Won Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2016
Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host DiseaseYayoi Matsumura-Kimoto, Yoshihiro Inamoto, Kinuko Tajima, et al.
American Journal of Hematology|May 30, 2012
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphomaKohei Tada, Sung-Won Kim, Yoshitaka Asakura, et al.
Pageof 4